Skip to main content
Article thumbnail
Location of Repository

Mycobacterium bolletii Respiratory Infections

By Toïdi Adékambi and Michel Drancourt


Contrary to other species in the Mycobacterium chelonae-abscessus complex, we reidentified M. bolletii strains isolated from 4 respiratory patients and found these strains to be uniformly resistant to clarithromycin. No mutations previously associated with macrolide resistance in bacteria were detected in either the 23S rDNA or the genes encoding riboproteins L4 and L22

Topics: Dispatch
Publisher: Centers for Disease Control and Prevention
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2009). Address for correspondence: Michel Drancourt, Unité des Rickettsies, Faculté de Médecine, 27 Blvd Jean Moulin,
  2. An offi cial ATS/IDSA statement: diagnosis, treatment, and revention of nontuberculous mycobacterial diseases.
  3. (2002). Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev.
  4. (2002). Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae. Antimicrob Agents Chemother.
  5. Emergence of nontuberculous mycobacteria as pathogens in cystic fi brosis.
  6. Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fi brosis.
  7. (1996). Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother.
  8. High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan. Antimicrob Agents Chemother.
  9. Identifi cation of an emerging pathogen, Mycobacterium massiliense, by rpoB sequencing of clinical isolates collected in the United States.
  10. (1994). Identifi cation of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrob Agents Chemother.
  11. (2006). Intrinsic macrolide resistance in rapidly growing mycobacteria. Antimicrob Agents Chemother.
  12. Molecular characterization of Mycobacterium massiliense and Mycobacterium bolletii in isolates collected from outbreaks of infections after laparoscopic surgeries and cosmetic procedures.
  13. (2008). Mycobacteries non-tuberculeuses et mucoviscidoses: enquête française de prevalence.
  14. rpoB gene sequencebased characterization of emerging non-tuberculous mycobacteria with descriptions of Mycobacterium bolletii sp. nov.,
  15. rpoB-based identifi cation of nonpigmented and late-pigmenting rapidly growing mycobacteria.
  16. Standards. Susceptibility testing of Mycobacteria, Nocardia, and other aerobic actinomycetes. Approved standard M24-A.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.